Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
Journal of Translational Medicine|August 16, 2018
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicityAngus G Dalgleish, Satvinder Mudan, Alberto FusiCancer Immunology, Immunotherapy : CII|June 22, 2011
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activationEdit Kovalcsik, Katie Lowe, Mike Fischer, et al.Melanoma Management|September 8, 2018
Dabrafenib and its use in the treatment of metastatic melanomaSamantha Bowyer, Rebecca Lee, Alberto Fusi, et al.International Journal of Oncology|January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibitionNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.European Journal of Cancer (Oxford, England : 1990)|May 17, 2011
Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneityAlberto Fusi, Rebecca Berdel, Swantje Havemann, et al.Lung Cancer (Amsterdam, Netherlands)|March 18, 2015
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancerMatthew Howell, Rebecca Lee, Samantha Bowyer, et al.Lung Cancer (Amsterdam, Netherlands)|April 29, 2008
Oxaliplatin doublets in non-small cell lung cancer: a literature reviewDiego Cortinovis, Paolo Bidoli, Nicoletta Zilembo, et al.Current Treatment Options in Oncology|September 3, 2013
Clinical utility of circulating tumour cell detection in non-small-cell lung cancerAlberto Fusi, Robert Metcalf, Matthew Krebs, et al.Cancer Immunology, Immunotherapy : CII|August 23, 2002
Immunotherapeutic potential of whole tumour cellsStephen Ward, David Casey, Marie-Christine Labarthe, et al.Melanoma Research|November 16, 2020
Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanomaWing K Liu, Nabeel Naban, Arvind Kaul, et al.Pageof 8